Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
05/26/2016
|
ZSPH |
|
PDUFA |
Other |
None |
|
05/26/2016
|
ZSPH |
|
PDUFA |
Other |
None |
|
Q1 2017
|
ZSAN |
|
Phase 1 Results |
Neurology |
None |
|
Q3 2016
|
AEZS |
|
Phase 3 Results |
Oncology |
None |
|
Q4 2016
|
FLXN |
|
NDA Submission |
Other |
None |
|
09/14/2016
|
ARLZ |
|
PDUFA |
Cardiovascular |
None |
|
10/22/2016
|
MDVN |
|
PDUFA |
Oncology |
None |
|
Q4 2016
|
MDVN |
|
Phase 3 Results |
Oncology |
None |
|
H1 2017
|
XNCR |
|
Phase 1 Results |
Respiratory |
None |
|
H1 2017
|
XNCR |
|
Phase 2 Results |
Other |
None |
|